Biogen Pharmachem News

    AllNewsAnnouncementRecos

    BSE LIVE

    Change:

    Volume:

    Open:

    Prv. Close:

    Today:

    Biogen Pharmachem Industries Ltd.

    52-Wk:

    Biogen Pharmachem Industries Ltd.

    Bid:

    ()

    Offer:

    ()

    NSE LIVE

    Change:

    Volume:

    Open:

    Prv. Close:

    Today:

    Biogen Pharmachem Industries Ltd.

    52-Wk:

    Biogen Pharmachem Industries Ltd.

    Bid:

    ()

    Offer:

    ()

    Biogen Pharmachem Industries Closure of Trading Window

    | Announcement

    PFA

    Biogen Pharmachem Industries Compliances-Reg.24(A)-Annual Secretarial Compliance

    | Announcement

    PFA

    Biogen Pharmachem Industries Board Meeting Outcome for Audited Financial Results Held On 25Th May, 2024

    | Announcement

    Outcome of the Board Meeting held on 25th May 2024.

    Biogen Pharmachem Industries Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2024.

    | Announcement

    Audited Financial Results for the Quarter and Year Ended on 31st March, 2024

    Biogen Pharmachem Industries Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

    | Announcement

    Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of theCompany will be held on Saturday 25th May 2024 at registered office of the company inter alia,to consider following business.1. Approve and take on record the Audited Standalone Financial Results of the Company forthe quarter and year ended on 3pt March 2024.2. Any other matter which the Board may think fit.Please take the above intimation in your records.Thanking You.

    Biogen Pharmachem Industries Submission Of Certificate By PCS Under Regulation 40(9) Of The SEBI (Listing Obligation & Disclosure Requirements) Regul...

    | Announcement

    PFA

    Biogen Pharmachem Industries Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    | Announcement

    PFA

    Biogen Pharmachem Industries Compliance Certificate Pursuant To Regulation 7(3) Of The SEDIListing Obligations And Disclosure Requirements) Reguiatio...

    | Announcement

    PFA

    Biogen Pharmachem Industries Closure of Trading Window

    | Announcement

    Intimation of Closure of Trading Window for considering the Audited Financial Results of the company for the Quarter and Year ended on 31.03.2024

    Biogen Pharmachem Industries Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations...

    | Announcement

    PFA

    Biogen Pharmachem Industries Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    | Announcement

    PFA

    Biogen Pharmachem Industries Shareholder Meeting / Postal Ballot-Outcome of EGM

    | Announcement

    PFA

    Biogen Pharmachem Industries Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat...

    | Announcement

    PFA

    Biogen Pharmachem Industries Board Meeting Outcome for Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of T...

    | Announcement

    Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Monday 22nd January 2024 .1.) Considered and approved Un-audited financial results for the quarter ended as on 31st December 2023.The meeting commenced at 04.15 P.M. and concluded at 04.45 P.M.Kindly take the same on your record and oblige.Thanking You

    Biogen Pharmachem Industries Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

    | Announcement

    Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday January 22 2024 inter alia, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities.Please take the above intimation in your records.Thanking You.

    Biogen Pharmachem Industries Notice Of Extra Ordinary General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obli...

    | Announcement

    PFA

    Biogen Pharmachem Industries Rectification Of Outcome Of Board Meeting Held Today 09.01.2024 And Pursuant To Regulation 30 Of SEBI (LODR) Regulations...

    | Announcement

    PFA

    Biogen Pharmachem Industries Board Meeting Outcome for Outcome Of Board Meeting Held Today 09.01.2024 And Pursuant To Regulation 30 Of SEBI (LODR) Re...

    | Announcement

    Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company held today 09th January 2024 inter alia, and consider following businesses.1. Ms. Chhaya Parmar is appointed as non-executive independent director of the company w e f. 09.01.2024 subject to approval of members.2. The board has considered and accepted the resignation of Independent Director Ms Manjula Parmar w e.f 09.01.2024.The board meeting started at 12.30 P.M. and concluded at 01.00. P M.Please take the same on your record.

    Biogen Pharmachem Industries Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    | Announcement

    PFA

    Biogen Pharmachem Industries Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

    | Announcement

    Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday January 9,2024 inter alia, to consider the appointment and Resignation of Director.Please take the above intimation in your records.Thanking You.

    Biogen Pharmachem Industries Closure of Trading Window

    | Announcement

    PFA

    Biogen Pharmachem Industries Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2023 Pursuant To Regulation 33 Of The SEBI (LO...

    | Announcement

    PFA

    Biogen Pharmachem Industries Board Meeting Outcome for Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2023 Pursuant To Reg...

    | Announcement

    In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2023 andThe meeting commenced at 04:30 P.M. and concluded at 05:00 P.M.Kindly take the same on your record and oblige.Thanking You

    Biogen Pharmachem Industries Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

    | Announcement

    Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, be and is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday, November 1, 2023 inter alia, to consider the Un-Audited financial results of the company for quarter and half year ended on September 30, 2023 and also transact other business activities. Please take the above intimation in your records.Thanking you.

    Biogen Pharmachem Industries Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    | Announcement

    PFA

    Biogen Pharmachem Industries Reg. 34 (1) Annual Report.

    | Announcement

    Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2022-23 along with the Notice of Annual General Meeting to be held on 27.09.2022.

    Biogen Pharmachem Industries Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations ...

    | Announcement

    PFA

    Biogen Pharmachem Industries Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listin...

    | Announcement

    PFA

    Biogen Pharmachem Industries Un-Audited Financial Result Quarter Ending 30Th June, 20223 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 20...

    | Announcement

    PFA

    Biogen Pharmachem Industries Board Meeting Outcome for Un-Audited Financial Result Quarter Ending 30Th June, 20223 Pursuant To Regulation 33 Of The S...

    | Announcement

    Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Thursday 10th August 2023 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2023.The board meeting concluded on 05.00. P.M.Please take the above intimation in your records.Thanking You,

    Biogen Pharmachem Industries Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

    | Announcement

    Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 10th August 2023 inter alia, to consider following business. -1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2023.2.) Any other matter with the permission of the board which the Board may think fit.Please take the above intimation in your records.Thanking You.

    Biogen Pharmachem Industries Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    | Announcement

    Please Find Enclosed

    Biogen Pharmachem Industries Clarification On Price Movement.

    | Announcement

    Please find enclosed.

    Biogen Pharmachem Industries Closure of Trading Window

    | Announcement

    Please Find Enclosed.

    In the Nifty pack, 41 stocks closed in the green, while 9 stocks ended in the red.

    Biogen Pharmachem Industries Clarification sought from Biogen Pharmachem Industries Ltd

    | Announcement

    The Exchange has sought clarification from Biogen Pharmachem Industries Ltd on June 30, 2023, with reference to Movement in Price. The reply is awaited.

    The NSE Nifty index was trading 93.85 points up at 18911.25

    In the Nifty pack, 38 stocks closed in the green, while 12 stocks ended in the red.

    The NSE Nifty index closed 126.2 points up at 18817.4

    In the Nifty pack, 32 stocks were trading in the green, while 16 stocks were trading in the red.

    The Economic Times